GC
DSCI

Globeflex Capital’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Globeflex Capital’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-340
Closed -$1K – 606
2016
Q2 		$1K Buy
+340
New +$1.27K ﹤0.01% 445

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Globeflex Capital's DSCI Position: Q3 2016 in Review

Globeflex Capital sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2016, closing a stake of 340 shares — an estimated $1K sold.

Globeflex Capital first reported a position in DSCI in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 61 funds tracked by Wall St. Rank hold DSCI as of Q3 2016.

  • Globeflex Capital reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2016 after selling out during the quarter.
  • Globeflex Capital sold 340 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2016, an estimated $1K.
  • Globeflex Capital first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2016 and held it in 1 quarter.
  • Globeflex Capital's Derma Sciences, Inc. Common Stock (DE) position peaked at $1K in Q2 2016.
  • 61 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2016.

Based on Globeflex Capital's 13F filing for Q3 2016, filed 9 Nov 2016.